News & Perspective

Jun 07, 2012

Jun 07, 2012

Drug-resistant TB studies show burden in China, new antibiotic results

(CIDRAP News) – Two groups of tuberculosis (TB) researchers released new findings today, giving the world its first look at drug-resistant TB at the national level in China and presenting encouraging findings for the new antibiotic delamanid for the multidrug-resistant (MDR) form of the disease.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»